Warning letter
RX South DBA RX3 Compounding Pharmacy LLC: warning letter of Oct 23, 2014
FDA warning letter 440735 · Baltimore District Office
Key facts
| Reference number | 440735 |
|---|---|
| Company | RX South DBA RX3 Compounding Pharmacy LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Oct 23, 2014 |
| Posted date | Nov 11, 2014 |
| Issuing office | Baltimore District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 200.10(b), 211.42(b), 211.42(c)(10)(iv), 211.42(c)(10)(vi), 211.113(b), 210.1(b) |
| Inspection city | Chester |
| Inspection ZIP | 23831 |
| Inspection start date | Jan 24, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: